Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS: Results From a Randomized Crossover Trial

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 14, 2022

Study Completion Date

December 28, 2022

Conditions

Management of Ureteric Stent Related LUTS and Pain

Interventions

DRUG

Tadalafil 5Mg Tab

PDE5 inhibitor

DRUG

Darifenacin 7.5 MG

anti muscarinic

Trial Locations (1)

Ain Shams University Hospita, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER